GlassScriptPhysician profile
Parija Sharedalal
NPI 1821447145
$8,625.85
in general payments reported to CMS, 2019-2025
31 companies · $1,800 in 2025
The $1,800 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $425 · 2020: $142 · 2021: $416 · 2022: $1,003 · 2023: $3,773 · 2024: $1,067 · 2025: $1,800.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,280 · Travel and Lodging: $1,235 · Grant: $1,126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,279.60 |
| Travel and Lodging | $1,234.74 |
| Grant | $1,126.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,120.63 | 2022-2025 | Avvigo Guidance System, Emerge Push, Wolverine Coronary Cutting Balloon |
| Zoll Circulation INC | $1,347.34 | 2023-2024 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Shockwave Medical, INC | $639.74 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $610.80 | 2023-2025 | Impella |
| Medtronic, INC. | $588.98 | 2022-2024 | Acist Rxi System, Onyx Frontier, Linq II |
| Abbott Laboratories | $572.75 | 2023-2025 | Aveir, Coroflow, Jot Dx |
| Astellas Pharma US INC | $297.00 | 2019-2020 | |
| Asahi Intecc USA, INC. | $252.70 | 2023 | Asahi Ptca Guide Wire |
| Janssen Pharmaceuticals, INC | $191.70 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $181.68 | 2024-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $179.26 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $167.64 | 2021-2025 | Farxiga |
| Pfizer INC. | $164.12 | 2019-2025 | |
| Acist Medical Systems, INC. | $149.81 | 2023 | |
| Philips North America LLC | $149.10 | 2023-2024 | (6496) Fm Other |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Opsens INC. | $148.09 | 2021 | |
| Edwards Lifesciences Corporation | $135.02 | 2025 | Sapien 3 Ultra Resilia |
| Cardiovascular Systems INC. | $120.20 | 2022 | |
| Kestra Medical Technology Services, INC. | $87.94 | 2025 | Assure Wcd |
| Lantheus Medical Imaging, INC. | $85.81 | 2019-2025 | Definity |
| Chiesi USA, INC. | $80.64 | 2020-2025 | Kengreal |
| Biotronik INC. | $64.62 | 2023 | Orsiro Mission |
| Biosense Webster, INC. | $59.26 | 2024-2025 | Carto 3 |
| Atricure, INC. | $59.21 | 2024-2025 | Atriclip Laa Exclusion System |
| Cvrx, INC. | $46.51 | 2025 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $28.54 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $28.48 | 2024-2025 | Camzyos |
| Novo Nordisk INC | $20.15 | 2025 | Ozempic |
| Penumbra, INC. | $18.10 | 2024 | Penumbra System |
| Kiniksa Pharmaceuticals International, Plc | $15.51 | 2024 | Arcalyst |
| La Jolla Pharmaceutical Company | $14.52 | 2024 | Giapreza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parija Sharedalal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.